NBY Chart
- 52-Week Range: $0.18 - $0.77
- Market Capitalization: $9.87M
- Short Percentage: 0%
- Target Price: $3.23
- Shares Outstanding: 51.42M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
NBY released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- NovaBay Pharmaceuticals to Hold First Quarter 2022 Conference Call on May 12Business Wire | May 5th
- NovaBay Pharmaceuticals, Inc. (NBY) CEO Justin Hall on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | March 29th
- NovaBay Pharmaceuticals to Hold 2021 Fourth Quarter and Full Year Conference Call on March 29Business Wire | March 22nd
- DERMAdoctor Launches New HA Serum to Expand Calm Cool + Corrected Product LineBusiness Wire | March 9th
- NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of StockholdersBusiness Wire | January 20th
- NovaBay Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual ConferenceBusiness Wire | January 4th
Company Info
Website: https://novabay.com
Address: 2000 Powell Street, EmeryVille, CA, United States, 94608
Sector: Healthcare
Industry: Biotechnology
Full time employees: 29
Address: 2000 Powell Street, EmeryVille, CA, United States, 94608
Sector: Healthcare
Industry: Biotechnology
Full time employees: 29
$NBY omg this is bullshit
$NBY is anyone really buying this shit
$NBY holy fuck
$NBY time to run
$NBY GET IN mofos!!!
$NBY is it time?
$NBY I need a smoke after this trade
$NBY Buy now
$NBY lmfao
lfg babies
$NBY back to business